PerfuseCell A/S — Credit Rating and Financial Key Figures

PerfuseCell A/S (CVR number: 31606810) is a company from HERLEV. The company reported a net sales of 0.6 mDKK in 2024, demonstrating a decline of -12.1 % compared to the previous year. The operating profit percentage was poor at -0 % (EBIT: -0 mDKK), while net earnings were 2.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 0.2 %, which can be considered weak and Return on Equity (ROE) was 0.2 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 69.1 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. PerfuseCell A/S's liquidity measured by quick ratio was 3.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.